PNET

Clinical trials for PNET explained in plain language.

Never miss a new study

Get alerted when new PNET trials appear

Sign up with your email to follow new studies for PNET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

New hope for VHL patients: belzutifan trial targets rare tumor disorder

Disease control Recruiting now

This study tests the drug belzutifan in 100 people with von Hippel-Lindau (VHL) syndrome, a genetic condition that causes tumors in various organs. Researchers will track how well the drug shrinks tumors and how long it takes for the disease to progress, while also monitoring sid…

Matched conditions: PNET

Phase: PHASE2 • Sponsor: José Claudio Casali da Rocha • Aim: Disease control

Last updated Jun 26, 2026 15:43 UTC

PNET

Get alerted when new PNET trials appear

New hope for VHL patients: belzutifan trial targets rare tumor disorder